National Cancer Center, Korea: Lung Neoplasms trials

The registry lists 23 Lung Neoplasms studies with National Cancer Center, Korea as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 17Phase 3 1No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Nivolumab After Cyclophosphamide and Doxorubicin Induction Therapy in NSCLC With PD-L1<10%Status unknownNCT03808480Phase 2
• Korean Lung Cancer Screening ProjectStatus unknownNCT03394703
• A Study of Tarceva vs. Avastin+Tarceva for Advanced NSCLC With EGFR m(+)Status unknownNCT03126799Phase 2
• Risk Factors of Medistinal Metastasis in Endoscopic Staging of Lung CancerActive, not recruitingNCT02991924
• Once Daily Accelerated Fractionation With Concomitant Boost to the Gross Tumor Volume Compared With Twice Daily Hyperfractionation in Concurrent Chemoradiation in Patients With Limited Disease Small Cell Lung CancerStatus unknownNCT01710956Phase 2
• Combined Application of EBUS and EUS in Lung CancerCompletedNCT01385111Not applicable
• Study of Sorafenib Maintenance in Patients With ED-SCLC After Response to Induction ChemotherapyTerminatedNCT01159327Phase 2
• BIBW 2992 Plus Simvastatin vs. BIBW 2992 in Previously Treated Patients With Advanced Non-adenocarcinomatous NSCLCCompletedNCT01156545Phase 2
• Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IVCompletedNCT01003964Phase 2
• Radiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung CancerStatus unknownNCT00955695Phase 3
• A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)Status unknownNCT00874328Phase 1/2
• Endobronchial Ultrasound Guided Transbronchial Needle Aspiration (EBUS-TBNA) for Mediastinal Re-staging of Non-small Cell Lung Cancer(NSCLC)WithdrawnNCT00859742Not applicable
• Mediastinal Staging of Lung Cancer With EBUS-TBNA and EUS-B-FNACompletedNCT00741247Not applicable
• Sunitinib as a Second-line Treatment for Patients With Recurrent Small Cell Lung CancerCompletedNCT00620347Phase 2
• Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC IIIStatus unknownNCT00620269Phase 2
• Weekly Paclitaxel Plus Gemcitabine as Second-line in Small Cell Lung CancerCompletedNCT00453167Phase 2
• Gemcitabine Plus Oxaliplatin in Advanced Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)Status unknownNCT00453115Phase 2
• Adjuvant Gemcitabine Plus Oxaliplatin Versus Gemcitabine Plus Cisplatin for Completely Resected Stage IB/II/IIIA NSCLCStatus unknownNCT00452881Phase 2
• Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in N2 Positive IIIA Non Small Cell Lung Cancer (NSCLC)Status unknownNCT00452803Phase 2
• Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC)CompletedNCT00452634Phase 2
• Gefitinib With or Without Simvastatin in Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00452244Phase 2
• VATS Lobectomy for Clinical Stage IB or II Lung CancerStatus unknownNCT00425022Phase 2
• Gemcitabine and Cisplatin Before or After Surgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung CancerStatus unknownNCT00398385Phase 2